Amrize Ltd Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 14 trades in Amrize Ltd (NYSE: AMRZ) since 2025, across 1 member, worth an estimated $112.01K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). Democratic members are responsible for 100% of the trades and Republican members 0%. The most recent disclosure shown was filed June 2026, and Rohit Khanna has filed the most AMRZ transactions among those shown, with 14. One notable disclosed move was a purchase by Rohit Khanna on February 4, 2026, down 20.4% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Amrize Ltd's current Quantellect Tide Score is 21 out of 100 (Low Tide), Bottom 6% of universe (3876); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Amrize Ltd (AMRZ) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Amrize congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Rohit Khanna House | Jun 9, 2026 | May 21, 2026 | 19 days | BUY |  $1,001 - $15,000 | -12.36% | Child | |
Rohit Khanna House | Jun 9, 2026 | May 21, 2026 | 19 days | BUY | $1,001 - $15,000 | -12.36% | Spouse | |
Rohit Khanna House | Mar 9, 2026 | Feb 4, 2026 | 33 days | BUY | $1,001 - $15,000 | -20.40% | Spouse | |
Rohit Khanna House | Feb 6, 2026 | Jan 30, 2026 | 7 days | BUY | $1,001 - $15,000 | -15.07% | Spouse | |
Rohit Khanna House | Dec 8, 2025 | Nov 4, 2025 | 34 days | BUY | $1,001 - $15,000 | -12.32% | Spouse | |
Rohit Khanna House | Nov 6, 2025 | Oct 24, 2025 | 13 days | BUY | $1,001 - $15,000 | -9.85% | Spouse | |
Rohit Khanna House | Nov 6, 2025 | Oct 20, 2025 | 17 days | BUY | $1,001 - $15,000 | -8.40% | Spouse | |
Rohit Khanna House | Nov 6, 2025 | Oct 17, 2025 | 20 days | BUY | $1,001 - $15,000 | -8.05% | Spouse | |
Rohit Khanna House | Nov 6, 2025 | Oct 15, 2025 | 22 days | BUY | $1,001 - $15,000 | -7.80% | Spouse | |
Rohit Khanna House | Nov 6, 2025 | Oct 14, 2025 | 23 days | BUY | $1,001 - $15,000 | -8.87% | Spouse |
Amrize (AMRZ) congressional trading FAQ
Can members of Congress legally trade Amrize (AMRZ) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Amrize (AMRZ), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Amrize (AMRZ) trades public?
Yes. Every congressional trade in Amrize (AMRZ) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Amrize (AMRZ)?
Members of Congress have disclosed 14 trades in Amrize (AMRZ) worth $112.01K across 1 members, according to public STOCK Act filings.
Which members of Congress have traded Amrize (AMRZ)?
Recent and active filers of Amrize (AMRZ) disclosures include Rohit Khanna. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Amrize (AMRZ) more?
Across disclosed Amrize (AMRZ) trades, 100% were by Democrats and 0% by Republicans, led by Democrats (100%).
What is the most recent congressional Amrize (AMRZ) trade?
The most recent disclosed Amrize (AMRZ) trade was a purchase by Rohit Khanna, filed Jun 8, 2026.
What is Amrize (AMRZ)'s Tide Score?
Amrize (AMRZ) has a Quantellect Tide Score of 21 (Low Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.
Browse all stocks Congress tradesCongressional trading overviewAmrize (AMRZ) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.